Molecular Docking of Opiates and Opioid Peptides, a Tool for the Design of Selective Agonists and Antagonists, and for the Investigation of Atypical Ligand-Receptor Interactions
Gentilucci, L.; Tolomelli, A.; De Marco, R.; Artali, R.
1587-1601
Converting Peptides into Drug Leads by Lipidation
Zhang, L.; Bulaj, G.
1602-1618
Ion Pore Formation in Lipid Bilayers and Related Energetic Considerations
Ashrafuzzaman, Md.; Tuszynski, J.
1619-1634
Role of Ligand-Based Drug Design Methodologies toward the Discovery of New Anti- Alzheimer Agents: Futures Perspectives in Fragment-Based Ligand Design
Speck-Planche, A.; Luan, F.; N.D.S. Cordeiro, M.
1635-1645
Molecular Property Filters Describing Pharmacokinetics and Drug Binding
T. Garcia-Sosa, A.; Maran, U.; Hetenyi, C.
1646-1662
Resveratrol in Medicinal Chemistry: A Critical Review of its Pharmacokinetics, Drug-Delivery, and Membrane Interactions
R. Neves, A.; Lucio, M.; L.C. Lima, J.; Reis, S.
1663-1681
Chemical Metabolism of Medicinal Compounds from Natural Botanicals
Lu, Q.; Jiang, J.-G.
1682-1705
Plant Polyphenols and Oral Health: Old Phytochemicals for New Fields
M. Varoni, E.; Lodi, G.; Sardella, A.; Carrassi, A.; Iriti, M.
1706-1720
In Vitro - In Vivo Correlation of Gene Expression Alterations Induced by Liver Carcinogens
Heise, T.; Schug, M.; Storm, D.; Ellinger-Ziegelbauer, H.; J. Ahr, H.; Hellwig, B.; Rahnenfuhrer, J.; Ghallab, A.; Guenther, G.; Sisnaiske, J.; Reif, R.; Godoy, P.; Mielke, H.; Gundert-Remy, U.; Lampen, A.; Oberemm, A.; G. Hengstler, J.
1721-1730
Nonmuscle Myosin Heavy Chain and Histone H3 are Intracellular Binding Partners of Lithospermic Acid B and Mediate its Antiproliferative Effect on VSMCs
H. Cho, Y.; Y. Lim, E.; M. Kim, J.; Jung, M.; C. Lee, H.; Seo, M.; J. Lee, E.
1731-1737